Promoter hypermethylation of SFRP1 as a prognostic and predictive blood-based biomarker in patients with stage IV pancreatic ductal adenocarcinoma.

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Original languageEnglish
Article numberB047
JournalCancer Research
Volume82
Issue numberSuppl. 22
Number of pages1
ISSN0008-5472
DOIs
Publication statusPublished - 15 Nov 2022
EventAACR Special Conference: Pancreatic Cancer - Sheraton Boston Hotel, Boston, United States
Duration: 13 Sept 202216 Sept 2022
https://www.aacr.org/professionals/meetings/previous-aacr-meetings/previous-aacr-meetings-2022/

Conference

ConferenceAACR Special Conference: Pancreatic Cancer
LocationSheraton Boston Hotel
Country/TerritoryUnited States
CityBoston
Period13/09/202216/09/2022
Internet address

Bibliographical note

Abstract No. B047

Cite this